Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As more bacteria evolve to evade even last-resort drugs, ...

When the CDC released the 2019 Antibiotic Resistance Threats in the United States report, VRE was listed as a serious threat. Enterococci are bacteria that are normally present in the human intestines ...

Vancomycin-resistant enterococci are a common cause of healthcare-associated infection. A literature review was conducted to understand the current evidence and support nurses and other health ...

Please provide your email address to receive an email when new articles are posted on . The array of health care-associated infections, ranging from catheter-associated UTIs to Clostridioides ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...

Ein kleines Molekül macht das besiegte Antibiotikum Vancomycin wieder wirksam gegen gefürchtete resistente Superkeime aus ...

Creating new vaccines is one of several possible strategies in the fight against antibiotic-resistant bacteria, in addition to using fewer antibiotics and using them smarter. One of the bacteria that ...

Enterococci are Gram-positive, facultative anaerobic cocci that colonise the gastrointestinal tracts of humans and animals yet have emerged as leading causes of multidrug-resistant hospital-acquired ...